Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial.
Stibbe JA, de Barros HA, Linders DGJ, Bhairosingh SS, Bekers EM, van Leeuwen PJ, Low PS, Kularatne SA, Vahrmeijer AL, Burggraaf J, van der Poel HG. Stibbe JA, et al. Among authors: van leeuwen pj, van der poel hg. Lancet Oncol. 2023 May;24(5):457-467. doi: 10.1016/S1470-2045(23)00102-X. Epub 2023 Apr 14. Lancet Oncol. 2023. PMID: 37062295 Clinical Trial.
Image navigation as a means to expand the boundaries of fluorescence-guided surgery.
Brouwer OR, Buckle T, Bunschoten A, Kuil J, Vahrmeijer AL, Wendler T, Valdés-Olmos RA, van der Poel HG, van Leeuwen FW. Brouwer OR, et al. Among authors: van der poel hg, van leeuwen fw. Phys Med Biol. 2012 May 21;57(10):3123-36. doi: 10.1088/0031-9155/57/10/3123. Epub 2012 May 1. Phys Med Biol. 2012. PMID: 22547491
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.
Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, Tammela TT, Rosario DJ, Gomez-Veiga F, Ahlgren G, Benzaghou F, Gaillac B, Amzal B, Debruyne FM, Fromont G, Gratzke C, Emberton M; PCM301 Study Group. Azzouzi AR, et al. Among authors: van der poel hg. Lancet Oncol. 2017 Feb;18(2):181-191. doi: 10.1016/S1470-2045(16)30661-1. Epub 2016 Dec 20. Lancet Oncol. 2017. PMID: 28007457 Free article. Clinical Trial.
Re: Karim A. Touijer, Robert Jeffery Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.
van Leeuwen PJ, van der Poel HG. van Leeuwen PJ, et al. Among authors: van der poel hg. Eur Urol. 2018 Jul;74(1):e15-e17. doi: 10.1016/j.eururo.2018.04.001. Epub 2018 Apr 13. Eur Urol. 2018. PMID: 29661485 No abstract available.
Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human translation.
Meershoek P, van Oosterom MN, Simon H, Mengus L, Maurer T, van Leeuwen PJ, Wit EMK, van der Poel HG, van Leeuwen FWB. Meershoek P, et al. Among authors: van leeuwen fwb, van oosterom mn, van leeuwen pj, van der poel hg. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):49-53. doi: 10.1007/s00259-018-4095-z. Epub 2018 Jul 27. Eur J Nucl Med Mol Imaging. 2019. PMID: 30054696 Free PMC article.
Gallium-68-prostate-specific membrane antigen (68 Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.
van Leeuwen PJ, Donswijk M, Nandurkar R, Stricker P, Ho B, Heijmink S, Wit EMK, Tillier C, van Muilenkom E, Nguyen Q, van der Poel HG, Emmett L. van Leeuwen PJ, et al. Among authors: van muilenkom e, van der poel hg. BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7. BJU Int. 2019. PMID: 30074667
441 results